Israeli Pharma Co. Wants NY Stock-Drop Class Suit Tossed
By Rachel Graf ( August 3, 2017, 3:16 PM EDT) -- An Israel-based pharmaceutical company urged a New York federal judge Wednesday to toss a proposed class action alleging it falsified late-stage trial results for a hypertension treatment and subsequently caused the company's share price to drop, saying the investors haven't sufficiently demonstrated how the purported falsification occurred....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.